VIDEO | 4:08:04
Memorial Sloan Kettering Cancer Center (MSK) hosted its first virtual clinical symposium in India, where we enjoyed robust presentations, question and answer sessions, and conversations with oncologists from across India. Topics included the inherent challenges and opportunities in studying cancers globally, new digital tools and pathways for managing cancer care, translational research, germline testing, and more.
Symposium Agenda and Presenters
| Title | Presenter |
|---|---|
Databases – Lessons From 3 Decades | Dr. Sir Murray Brennan, Senior Vice President of International Programs; Benno C. Schmidt Chair in Clinical Oncology |
| Going Forward – Reaping the Investment | Dr. Mrinal Gounder, Medical Oncologist; Physician Ambassador to India and Asia |
| Challenges and Opportunities for Studying Cancers Globally | Dr. Jatin Shah, Elliot W. Strong Chair in Head and Neck Oncology |
| Ayushman Bharat Digital Mission | Shri RS Sharma, CEO, National Health Authority (India) |
| Digital Pathology Evolution at MSK – The Springboard to AI | Dr. Meera Hameed, Chief, Surgical Pathology Service |
| Translational Research at MSK – The Road Ahead | Dr. Ross Levine, Laurence Joseph Dineen Chair in Leukemia Research; Chief, Molecular Cancer Medicine Service, HOPP; Deputy Physician-In-Chief, Translational Research, Memorial Hospital |
| Environment and Cancer – Obesity, Inflammation, and Cancer | Dr. Neil Iyengar, Medical Oncologist, and Dr. Atul Batra, Associate Professor of Medical Oncology (All India Institute of Medical Sciences, New Delhi) |
| The Role of the Intestinal Microbiome in Cancer Immunotherapy | Dr. Marcel van den Brink, Head, Division of Hematologic Malignancies; Alan N. Houghton Chair |
| Germline Testing to Inform Inherited Cancer Diagnosis, Management, and Prevention | Dr. Kenneth Offit, Chief, Clinical Genetics Service; Robert and Kate Niehaus Chair in Inherited Cancer Genomics |
| Overview of Phase I (Early Drug Development) Program at MSK and Potential for Collaborative Clinical Trials | Dr. Alexander Drilon, Chief, Early Drug Development Service |
| Childhood Cancers – Progress and Promise | Dr. Andrew Kung, Chair, Department of Pediatrics |
| Conclusion | Dr. Sir Murray Brennan |